Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent

被引:29
|
作者
Loeper, J [1 ]
Louérat-Oriou, B [1 ]
Duport, C [1 ]
Pompon, D [1 ]
机构
[1] Univ Paris 06, CNRS, Lab Propre Associe, Ctr Genet Mol, F-91198 Gif Sur Yvette, France
关键词
D O I
10.1124/mol.54.1.8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP2D6, a xenobiotic metabolizing cytochrome P450 (P450), was found to be present in significant amount on the outer face of cell plasma membrane in addition to the regular microsomal location. Present work demonstrates that this external P450 is catalytically competent and that activity is supported by NADPH-P450 reductase present on the inner face of plasma membrane. Purified plasma membranes from yeast expressing CYP2D6 sustained NADPH- and cumene hydroperoxide-dependent dextromethorphan demethylation and NADPH-cytochrome c activity confirming previous observations in human hepatocytes. CYP2D6 found on the outside of plasma membrane (by differential immune-inhibition and acidic shift assays on transformed spheroplasts) was catalytically competent at the cell surface for NADPH-supported activities. Anti-yeast P450-reductase antibodies inhibited neither CYP2D6 nor P450-reductase activities upon incubation with intact spheroplasts. In contrast, both activities were inhibited on isolated plasma membrane fragments. This highly suggested a cytosolic-orientation of the plasma membrane P450-reductase. This finding was confirmed by immunostaining in confocal microscopy. Finally, gene deletion of P450-reductase caused a complete loss of plasma membrane NADPH-supported CYP2D6 activity, which suggests that the reductase participates to some degree in the transmembrane electron transfer chain. This work illustrates that the outside-exposed plasma membrane CYP2D6 is active and may play an important metabolic role.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 50 条
  • [21] Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects
    Gaedigk, A
    Ndjountché, L
    Gaedigk, R
    Leeder, JS
    Bradford, LD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) : 575 - 576
  • [22] Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population
    Salyakina, Daria
    Roy, Sharmeen
    Wang, Weize
    Oliva, Mailin
    Akhouri, Rohan
    Sotto, Ileana
    Mulas, Nicole
    Solano, Rafaela
    Fernandez, Jose R.
    Sanchez, Stephanie
    Shamshad, Uzma
    Perlyn, Chad
    McCafferty-Fernandez, Jennifer
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (09):
  • [24] Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine
    Madadi, Parvaz
    Ciszkowski, Catherine
    Gaedigk, Andrea
    Leeder, J. Steven
    Teitelbaum, Ronni
    Chitayat, David
    Koren, Gideon
    CURRENT DRUG SAFETY, 2011, 6 (01) : 36 - 39
  • [25] Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)
    Desta, Z
    Kerbusch, T
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 10 - 20
  • [26] Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results
    Druid, H
    Holmgren, P
    Carlsson, B
    Ahlner, J
    FORENSIC SCIENCE INTERNATIONAL, 1999, 99 (01) : 25 - 34
  • [27] Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR
    Bodin, L
    Beaune, PH
    Loriot, MA
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2005, (03): : 248 - 253
  • [28] Cytochrome P450 2D6 as a Model Antigen
    Christen, Urs
    Holdener, Martin
    Hintermann, Edith
    DIGESTIVE DISEASES, 2010, 28 (01) : 80 - 85
  • [29] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [30] The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine
    Davis, MP
    Homsi, J
    SUPPORTIVE CARE IN CANCER, 2001, 9 (06) : 442 - 451